Evidence map›Paper›PMID 41488327›Full record

ArticleFrontiers in neuroscience2025

Sulfate reducing bacteria induce α-synuclein in intestinal and neuronal cells and tissues and inhibit tyrosine hydroxylase in neuronal cells.

Sudha B Singh, Arianne J Capacio, Cody A Braun, Amanda Carroll-Portillo, Sephira Ryman, Henry C Lin

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sudha B SinghBiomedical Research Institute of New Mexico, Albuquerque, NM, United States.
Arianne J CapacioBiomedical Research Institute of New Mexico, Albuquerque, NM, United States.
Cody A BraunBiomedical Research Institute of New Mexico, Albuquerque, NM, United States.
Amanda Carroll-PortilloDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, United States.
Sephira RymanDepartment of Translational Neuroscience, The Mind Research Network, Albuquerque, NM, United States.
Henry C LinDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University of New Mexico, Albuquerque, NM, United States.

Funding

Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseasesR01NS133569 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Sephira Ryman · 2023 to 2026
$3.2M
NINDS NIH HHS R01 NS133569
6 · The paper itself

Abstract

Introduction: Parkinson's disease (PD), a synucleopathy characterized by the presence of α-synuclein (α-syn) aggregates in the brain, is thought to originate in the intestine. Methods: Enteroendocrine STC-1 and neuronal SH-Sy5y cells were infected with Results: We found that DSV increased the number of STC-1cells with α-syn aggregates and also induced α-syn expression in these cells. Sup from DSV-infected STC-1 had higher α-syn levels compared to control uninfected sup and could induce α-syn aggregates in SH-Sy5y. DSV also directly induced a syn aggregates and inhibited TH in SH-Sy5y. DSV-gavaged mice had higher levels of α-syn in the duodenum, plasma, and in brain and also showed a decreasing trend in TH expression in the brain. Conclusion: Thus, our findings provide a gut-to-brain link tied to the ability of SRB in the gut-to increase expression, aggregation and spread of α-syn and decrease of TH in PD.

Indexed as

Desulfovibrio vulgaris (DSV)Parkinson’s diseasesulfate reducing bacteriatyrosine hydroxylaseα-synuclein (α-syn)

Identifiers

PMID41488327
PMCPMC12756163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.